Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer

NCT00492258 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1656

Enrollment

OTHER_GOV

Sponsor class

Conditions

Kidney Cancer

Interventions

DRUG: sorafenib tosylate
PROCEDURE: adjuvant therapy

Sponsor

Medical Research Council